Guest column: Now is the time to plan for the future of Houston's tech economy

guest column

Leaders across the spectrum are coming together this week to shine a spotlight on the future of tech jobs in Houston. Photo via Getty Images

This week, leaders in government, business, and academia are convening to work within the community to explore how we can leverage partnerships and new federal programs to drive investment into Houston’s burgeoning innovation ecosystem.

At AI Across America: Houston, we’ll begin forming plans and partnerships capable of sparking an innovation ecosystem, fueling AI education, training, research, development, and job creation. We’ll also examine how students, workers, businesses, and academics in the community can prepare for upcoming opportunities and challenges.

Why Houston

Besides being near Texas’ 10th District, choosing Houston was easy in its own right. According to a study by Axios and LinkedIn, between 2020 and 2021, while the traditional tech hubs bled top talent, Houston gained 10.6 percent new tech workers. Those workers arrived to a solid foundation; in 2022 the Houston metro area had net tech employment of 134,436 people. The growth is steady too. From 2010 to 2019, the Houston area tech workforce grew 12.3 percent.

Recently, Houstonians are leveraging federal programs and public-private partnerships to build innovative, collaborative environments. These include places like The Ion, East End Maker Hub, and Houston Community College.

Defining the project

The AI Across America project is a collaboration between SeedAI, a 501(c)3 nonprofit, and the Congressional AI Caucus. Working in conjunction, the organizations support efforts in the public and private sectors to expand access to AI education, training, development, testing, and job creation for communities across the country.

The AI Caucus is a group of U.S. Representatives working together to better understand their constituent's interests and those of all Americans as it pertains to AI. The organization works to explain the underlying technology and the ecosystem.

SeedAI does the groundwork to build collaboration across the private sector, government, academia, and civil society to support community-driven AI investments. The work of SeedAI focuses specifically on people who have been historically-marginalized and overlooked.

This is a critical moment for AI in America and beyond

AI is the battleground of the next great global competition. We have to be the first to build and master AI technology. Yet, because AI is a reflection of the people creating it and historical data, pursuing technology through the perspective of only a small group of people opens us to disproportionate harm and unknown risks.

Worse still, if the barrier to entry for AI is allowed to continue growing, we risk losing our most precious resource – the ingenuity waiting to be unleashed across the country. How, in those circumstances, can we succeed when faced with a nation like China with a population dwarfing the U.S. alongside an ability to spend far more agilely and extensively?

How can we succeed, and what is Houston’s role?

Fortunately, through recently-passed legislation called the Chips and Science Act, we have an opportunity to reclaim international leadership in a quintessentially American way: by leveraging the diverse strengths of communities across the country.

Houston already has a head start and an expanding tech economy – with planning and collaboration, Houstonians can be first in line to build new resources for AI education and development. When every state and community begins to realize their potential in the AI-powered future, Houston can play a leading role in guiding others to success and enabling their transformation.

If we succeed, we’ll uncover ingenuity and inventions we would’ve never anticipated. And as AI becomes easier to apply, we’ll have a real chance to build an AI-first generation of workers and builders from coast to coast.

Once we become competitive internally, we will be unbeatable internationally. If we succeed, we’ll lead the world in economic competitiveness and national security for decades to come.

------

Austin Carson is the founder of SeedAI, a nonprofit established to work with a diverse group of policymakers, academics, and private sector experts to help communities across the United States access the resources they need to engage with AI. Congressman Michael T. McCaul, Republican Leader for the House Foreign Affairs Committee and Vice Chair of the Congressional AI Caucus, is currently serving his ninth term representing Texas' 10th Congressional District which stretches from the city of Austin to the Houston suburbs.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings